Urinary Incontinence (UI)NCT06951022
The Effect of Sujok Therapy on Urinary Incontinence and Quality of Life in Postmenopausal Women
A study testing Sujok therapy in people with Urinary Incontinence (UI) and Postmenopause, run by Inonu University at 1 site in Turkey (Türkiye).
Trial summary
This study aims to investigate the effect of Su Jok therapy, a complementary medicine practice, on urinary incontinence and quality of life among postmenopausal women. A total of 120 participants will be included in the study, with 60 in the intervention group and 60 in the control group. Read more about this study
- Who is it for?
- Ages Up to 65 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Urinary Incontinence (UI), Postmenopause
- What is being tested?
- Sujok therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 30 Jan 2025to 30 Jul 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 65 years
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Women under 65 years of age in the postmenopausal period, Literate, No speech or communication impairment
Who cannot join
- Use of diuretics
- Presence of nephrotic syndrome
- Diagnosis of diabetes or hypertension
- Symptoms of urinary tract infection
- Diagnosis of psychiatric illness
- History of urinary tract surgery
- Diagnosed urinary prolapse
- Failure to complete the intervention
Trial locations and contacts
1 site in 1 country.
About this study
This study aims to investigate the effect of Su Jok therapy, a complementary medicine practice, on urinary incontinence and quality of life among postmenopausal women. A total of 120 participants will be included in the study, with 60 in the intervention group and 60 in the control group. Participants in the intervention group will receive Su Jok seed therapy applied to the hand reflex points corresponding to the bladder. The therapy will be administered by the researcher and then taught to the participants, who will continue the application for 15 days. Assessments will be conducted at baseline, day 15, and day 30 using validated questionnaires.
- Conditions
- Urinary Incontinence (UI), Postmenopause
- Being tested
- Sujok therapy
- Keywords
- Su Jok Therapy, Urinary Incontinence, Quality of Life, Postmenopausal Women
- Medical subject headings
- Urinary Incontinence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sujok therapyOther
Participants in the intervention group will receive seed therapy using apple seeds applied to specific hand points corresponding to the bladder area.
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Participants in the intervention group will receive seed therapy using apple seeds applied to specific hand points corresponding to the bladder area. Receives: Other: Sujok therapy |
| Control | No intervention | standard care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in urinary incontinence symptoms measured by the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)
Description: The ICIQ-SF is a 4-item questionnaire used to evaluate the severity and impact of urinary incontinence.
Scoring: Scores range from 0 to 21, with higher scores indicating more severe urinary incontinence.
Unit of Measure: Points on a scale
Measured: At baseline, 15 days and 30 days after intervention
Change in quality of life measured by the Incontinence Quality of Life Scale (I-QOL)
Description: The I-QOL assesses quality of life, including behavioral limitation, psychosocial impact, and social isolation, in postmenopausal women with urinary incontinence.
Scoring: Domain scores range from 0 to 100, where higher scores represent a poorer quality of life.
Unit of Measure: Total score (0-100)
Measured: At baseline, 15 days and 30 days after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Apr 2025
- Study start30 Jan 2025
- Primary completion30 Jul 2025 (estimated)
- Study completion30 Jul 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Urinary Incontinence (UI)Studies of the same condition, open and under way.
- More trials run by Inonu UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants in the experimental group will receive Su Jok seed therapy using apple seeds applied to the hand point that reflects the bladder. Participants will be trained to perform the therapy themselves and will apply it daily for 15 days. They will be reminded via daily messages and monitored for adherence.
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Inonu University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gülçin NACAR, Inonu University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06951022
- Sponsor's protocol ID
- 2024/5494
- Status last verified
- Apr 2025
- First submitted
- 11 Apr 2025
- Last updated
- 30 Apr 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 30 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Sujok Therapy on Urinary Incontinence and Quality of Life in Postmenopausal Women
- ClinicalTrials.gov ID
- NCT06951022
- Acronym / sponsor ID
- 2024/5494
- Conditions
- Urinary Incontinence (UI), Postmenopause
- Keywords
- Su Jok Therapy, Urinary Incontinence, Quality of Life, Postmenopausal Women
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Inonu UniversityUniversity, hospital or other
- Study start
- 30 Jan 2025 (actual)
- Primary completion
- 30 Jul 2025 (estimated)
- Study completion
- 30 Jul 2025 (estimated)
- First posted
- 30 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the effect of Su Jok therapy, a complementary medicine practice, on urinary incontinence and quality of life among postmenopausal women. A total of 120 participants will be included in the study, with 60 in the intervention group and 60 in the control group. Participants in the intervention group will receive Su Jok seed therapy applied to the hand reflex points corresponding to the bladder. The therapy will be administered by the researcher and then taught to the participants, who will continue the application for 15 days. Assessments will be conducted at baseline, day 15, and day 30 using validated questionnaires.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants in the experimental group will receive Su Jok seed therapy using apple seeds applied to the hand point that reflects the bladder. Participants will be trained to perform the therapy themselves and will apply it daily for 15 days. They will be reminded via daily messages and monitored for adherence.
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Other: Sujok therapyParticipants in the intervention group will receive seed therapy using apple seeds applied to specific hand points corresponding to the bladder area. |
| Control | No intervention | –standard care |
Who may qualify
- Ages
- Up to 65 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Women under 65 years of age in the postmenopausal period, Literate, No speech or communication impairment
Key exclusion criteria (8 listed)
- Use of diuretics
- Presence of nephrotic syndrome
- Diagnosis of diabetes or hypertension
- Symptoms of urinary tract infection
- Diagnosis of psychiatric illness
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sujok therapyParticipants in the intervention group will receive seed therapy using apple seeds applied to specific hand points corresponding to the bladder area. | Other | Intervention |
Primary outcome
Change in urinary incontinence symptoms measured by the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)
Time frame: At baseline, 15 days and 30 days after intervention
Description: The ICIQ-SF is a 4-item questionnaire used to evaluate the severity and impact of urinary incontinence. Scoring: Scores range from 0 to 21, with higher scores indicating more severe urinary incontinence. Unit of Measure: Points on a scale
Change in quality of life measured by the Incontinence Quality of Life Scale (I-QOL)
Time frame: At baseline, 15 days and 30 days after intervention
Description: The I-QOL assesses quality of life, including behavioral limitation, psychosocial impact, and social isolation, in postmenopausal women with urinary incontinence. Scoring: Domain scores range from 0 to 100, where higher scores represent a poorer quality of life. Unit of Measure: Total score (0-100)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Apr 2025.
- Individual participant dataSharing planned: Yes
Related trials for Urinary Incontinence (UI)
Active, not recruitingObservational study
Overactive Bladder Symptoms and Urinary Incontinence In Women With Rheumatoid Arthritis
Rheumatoid Arthritis, Rheumatoid Arthritis (RA)
Not yet recruitingObservational study
Clinical, Functional, and Therapeutic Characterization of Women With Urinary Incontinence and Analysis of Factors Associated With Treatment Response
Urinary Incontinence (UI)
Recruiting
Ambulatory Long Length URodynamics Evaluation
Urology, Urinary Bladder, Overactive
Recruiting
Comparing the Effect of Two Types of Pelvic Floor Muscle Stimulation Devices to Improve Symptoms of Urinary Incontinence in Women.
Urinary Incontinence, Mixed Urinary Incontinence
Not yet recruiting
Transcutaneous Tibial Nerve Stimulation for Urinary Incontinence After Radical Prostatectomy
Urinary Incontinence (UI), Prostatectomy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Sujok therapy in people with Urinary Incontinence (UI) and Postmenopause, run by Inonu University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 30 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in urinary incontinence symptoms measured by the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) (time frame: At baseline, 15 days and 30 days after intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2025.